跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,432 条关于
“Chengdu Baiyu Pharmaceutical”
全部
13,432
临床试验
575
药物
1,773
机构
2,180
资讯
8,904
去年
Regulatory Setbacks for PTC's Translarna, Eisai/Biogen's Leqembi; Novartis Licenses Cancer Drug from Chengdu Baiyu
7个月前
Novartis Streamlines Oncology Pipeline, Discontinues Six Phase 1 Cancer Programs
去年
GLP-1s Show Promise in Addiction Treatment, Novavax Faces Vaccine Setback
8年前
Sanofi Establishes €66 Million Global R&D Hub in Chengdu, Expanding China Research Footprint
去年
WuXi Biologics Breaks Ground on China's First Dual-Chamber Lyophilization Manufacturing Site in Chengdu
去年
Chengdu UCELLO Biotech's UC101 Becomes First Allogeneic Universal CAR-T Therapy to Receive FDA IND Approval
去年
Dual-Payload ADCs Enter Clinical Testing as Innovent and Chengdu Kanghong Pioneer Next-Generation Cancer Therapeutics
11个月前
Biokin Pharmaceutical Receives NMPA Approval for First-in-Class Radiopharmaceutical [177Lu]-BL-ARC001
上个月
Grand Pharma's FAP-Targeted Radiopharmaceutical GPN01530-2 Earns FDA Fast Track Designation for Solid Tumor Diagnosis
4个月前
C-Ray Therapeutics Secures FDA Approval for Copper-64 Drug Master File, Advancing Next-Generation PET Diagnostics
第 1 页，共 891 页
上一页
下一页
